Boltwood Capital Management’s Merck MRK Stock Holding History

Boltwood Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764K	Buy	5,943 +100	+2%	+$11.7K	0.18%	114
2026 Q1	$703K	Buy	5,843 +150	+3%	+$17.3K	0.18%	104
2025 Q4	$599K	Sell	5,693 -60	-1%	-$5.63K	0.16%	116
2025 Q3	$483K	Buy	5,753 +25	+0.4%	+$2.06K	0.13%	130
2025 Q2	$453K	Sell	5,728 -55	-1%	-$4.37K	0.13%	134
2025 Q1	$519K	Buy	5,783 +45	+0.8%	+$4.2K	0.16%	117
2024 Q4	$571K	Sell	5,738 -100	-2%	-$10.3K	0.17%	102
2024 Q3	$663K	Buy	5,838 +75	+1%	+$8.91K	0.2%	96
2024 Q2	$713K	Buy	5,763 +30	+0.5%	+$3.86K	0.22%	92
2024 Q1	$756K	Sell	5,733 -25	-0.4%	-$3.08K	0.23%	92
2023 Q4	$628K	Sell	5,758 -200	-3%	-$20.8K	0.21%	101
2023 Q3	$613K	Sell	5,958 -125	-2%	-$13.5K	0.23%	93
2023 Q2	$702K	Sell	6,083 -150	-2%	-$17K	0.25%	90
2023 Q1	$663K	Sell	6,233 -50	-0.8%	-$5.4K	0.25%	92
2022 Q4	$697K	Sell	6,283 -50	-0.8%	-$5.11K	0.28%	86
2022 Q3	$545K	Hold	6,333	–	–	0.25%	91
2022 Q2	$577K	Hold	6,333	–	–	0.25%	97
2022 Q1	$520K	Hold	6,333	–	–	0.2%	109
2021 Q4	$485K	Sell	6,333 -1,706	-21%	-$136K	0.18%	113
2021 Q3	$604K	Sell	8,039 -100	-1%	-$7.61K	0.24%	102
2021 Q2	$633K	Sell	8,139 -495	-6%	-$36.8K	0.26%	96
2021 Q1	$635K	Sell	8,634 -466	-5%	-$34.4K	0.28%	91
2020 Q4	$710K	Sell	9,100 -159	-2%	-$12.2K	0.34%	85
2020 Q3	$733K	Hold	9,259	–	–	0.41%	80
2020 Q2	$683K	Hold	9,259	–	–	0.41%	77
2020 Q1	$680K	Sell	9,259 -69	-0.7%	-$5.42K	0.48%	71
2019 Q4	$810K	Hold	9,328	–	–	0.45%	75
2019 Q3	$749K	Sell	9,328 -210	-2%	-$16.8K	0.47%	73
2019 Q2	$763K	Hold	9,538	–	–	0.49%	75
2019 Q1	$757K	Sell	9,538 -366	-4%	-$27.4K	0.49%	70
2018 Q4	$722K	Hold	9,904	–	–	0.49%	68
2018 Q3	$670K	Hold	9,904	–	–	0.4%	86
2018 Q2	$573K	Sell	9,904 -375	-4%	-$21.2K	0.37%	88
2018 Q1	$534K	Sell	10,279 -201	-2%	-$10.9K	0.37%	85
2017 Q4	$562K	Hold	10,480	–	–	0.34%	85
2017 Q3	$640K	Hold	10,480	–	–	0.42%	77
2017 Q2	$640K	Sell	10,480 -314	-3%	-$19.1K	0.43%	78
2017 Q1	$654K	Sell	10,794 -10,632	-50%	-$645K	0.46%	76
2016 Q4	$1.2M	Sell	21,426 -105	-0.5%	-$6.14K	0.92%	37
2016 Q3	$1.28M	Buy	21,531 +188	+0.9%	+$11K	1.03%	36
2016 Q2	$1.17M	Buy	21,343 +435	+2%	+$23.2K	0.98%	36
2016 Q1	$1.06M	Buy	20,908 +3,668	+21%	+$180K	0.93%	38
2015 Q4	$869K	Buy	17,240 +629	+4%	+$31.7K	0.8%	42
2015 Q3	$783K	Buy	16,611 +79	+0.5%	+$4.2K	0.83%	41
2015 Q2	$898K	Sell	16,532 -63,217	-79%	-$3.55M	0.88%	40
2015 Q1	$4.37M	Sell	79,749 -786	-1%	-$44.5K	1.28%	26
2014 Q4	$4.36M	Sell	80,535 -191,805	-70%	-$10.7M	1.25%	28
2014 Q3	$15.4M	Sell	272,340 -24,890	-8%	-$1.4M	4.56%	5
2014 Q2	$16.4M	Sell	297,230 -8,855	-3%	-$483K	4.84%	3
2014 Q1	$16.6M	Sell	306,085 -1,677	-0.5%	-$86.8K	5.22%	3
2013 Q4	$14.7M	Sell	307,762 -52	-0%	-$2.38K	4.81%	4
2013 Q3	$14M	Buy	307,814 +92,638	+43%	+$4.23M	5.06%	3
2013 Q2	$9.54M	Buy	+215,176	New	+$9.61M	3.93%	6

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Boltwood Capital Management's MRK Position: Q2 2026 in Review

Boltwood Capital Management increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $11.7K and bringing the position to 5,943 shares worth $764K. The position accounts for 0.18% of the portfolio, ranked #114.

Boltwood Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.6M in Q1 2014. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Boltwood Capital Management held 5,943 shares of Merck worth $764K as of Q2 2026.
Boltwood Capital Management bought 100 Merck shares in Q2 2026, an estimated $11.7K.
Merck made up 0.18% of Boltwood Capital Management's portfolio in Q2 2026, its #114 holding.
Boltwood Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Boltwood Capital Management's Merck position peaked at $16.6M in Q1 2014.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Boltwood Capital Management's 13F filing for Q2 2026, filed 6 Jul 2026.